Stories You Saw On Social
Elizabeth Jaffee, MD, Feature in the Baltimore Banner
Forging Ahead
Silence Won’t Save Science
NIH Funding – Get Involved
NIH Layoffs | Rolling Stone Magazine
2024 Annual Report
Recent Funding Challenges: Know the Facts
Find a Walk Near You
Jack Statfeld | The Ripple Effect
Break Through Cancer – Novel TeamLab Focuses on Conquering KRAS in Pancreatic Cancer
WSJ: The RAS(ON) inhibitor, Daraxonrasib, from Revolution Medicines, shows promise in treating pancreatic cancer
2025 Atlanta Walk
Sommer Bazuro | Black History Month
Transform Pancreatic Cancer into a Curable Disease
PROCLAIM Study
International Women’s Day Symposium: The Power of Persistence – Women Transforming Cancer Research and Care
Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced 
Finding Clinical Trials for Pancreatic Cancer
Sign up to Volunteer
Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center, Awarded Lustgarten Grant Focusing on Racial Disparities in Pancreatic Cancer
LF-Funded Research: MICAL2 Promotes Pancreatic Cancer Growth and Metastasis
Break Through Cancer and Revolution Medicines Collaborate to Study Biomarkers for RAS(ON) Inhibitor in Pancreatic Cancer
LUSTGARTEN FOUNDATION FLAGSHIP WALK INSPIRES COMMUNITY AND RAISES CRITICAL DOLLARS FOR PANCREATIC CANCER RESEARCH
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
Johns Hopkins Medicine: Performance of explainable artificial intelligence in guiding the management of patients with a pancreatic cyst
Social Media Toolkit
The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer Research
New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study
Research Matters 2024
3D genomic mapping reveals multifocality of human pancreatic precancers
Blood Test Accurately Detects Early-Stage Pancreatic Cancer | NCI
Warren Alpert Foundation Donates $500,000 for Research
Laura Wood, MD, PhD | 3D Analysis of Human Pancreatic Tissue to Improve Early Detection of Pancreatic Cancers
LUSTGARTEN-FUNDED RESEARCH: Immune Response to Investigational RNA Vaccine for Pancreatic Cancer Continues to Correlate with Clinical Benefit
LUSTGARTEN-FUNDED RESEARCH: Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas
LUSTGARTEN-FUNDED RESEARCH: Researchers at the University of Toronto have discovered a key issue with a commonly-used chemotherapy drug
The Prompt with Trevor Noah: How AI can help clinicians improve pancreatic cancer detection?
Lustgarten receives $550,000 grant towards next phase of Organoids for Personalized Therapy (OPT) Project
New FDA Approval Brings More Treatment Options in Metastatic Disease
Current Funding Opportunities
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression
After Giving Up on Cancer Vaccines, Doctors Start to Find Hope
PASS-01 Trial: Predicting Tumor Response
Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models
Artificial Intelligence in Pancreatic Cancer Research
Detecting Cancer Early Through a Single Blood Test
New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase After Promising Results
Cold Spring Harbor Organoid Facility Tour
Pancreatic Cancer Collective
Find a Walk Near You
WATCH | Dr. Elizabeth Jaffee Awarded Johns Hopkins School of Medicine Dean’s Distinguished Mentoring Award
Immunotherapy for Pancreatic Cancer
New York Times | Pancreatic Cancer Vaccine Shows Promise in Small Trial
Lustgarten LABS Program
DONATE
Career Development Awards Honoring Ruth Bader Ginsburg and John Robert Lewis
Lustgarten Foundation Announced Grant Programs to Inspire and Diversify Talent in Pancreatic Cancer Research
Signs and Symptoms of Pancreatic Cancer
Support Lustgarten on FreeWill

Thanks for signing up!
Tell us a little more about yourself: